Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
702.00
+3.00 (0.43%)
At close: May 7, 2025
85.96%
Market Cap 110.55B
Revenue (ttm) 40.47M
Net Income (ttm) -545.92M
Shares Out 154.61M
EPS (ttm) -2.72
PE Ratio n/a
Forward PE 69.32
Dividend n/a
Ex-Dividend Date n/a
Volume 974,796
Average Volume 1,682,935
Open 711.00
Previous Close 699.00
Day's Range 699.00 - 718.00
52-Week Range 240.50 - 800.00
Beta 0.70
RSI 54.62
Earnings Date May 9, 2025

About TPE:6919

Caliway Biopharmaceuticals Co., Ltd. engages in the development of new drugs for aesthetic medicine and chronic inflammatory diseases. It also engages in clinical trial services and research and development patent applications. The company was incorporated in 2012 and is based in New Taipei City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6919
Full Company Profile

Financial Performance

In 2024, TPE:6919's revenue was 44.43 million, an increase of 14.13% compared to the previous year's 38.93 million. Losses were -588.83 million, 20.5% more than in 2023.

Financial Statements

News

There is no news available yet.